(19)
(11) EP 2 780 029 A1

(12)

(43) Date of publication:
24.09.2014 Bulletin 2014/39

(21) Application number: 11875859.8

(22) Date of filing: 18.11.2011
(51) International Patent Classification (IPC): 
A61K 38/22(2006.01)
A61K 31/203(2006.01)
A61K 38/05(2006.01)
A61P 3/00(2006.01)
C07K 14/575(2006.01)
 A61K 31/198(2006.01)
A61K 31/56(2006.01)
A61K 38/57(2006.01)
C07K 7/02(2006.01)
C07K 14/81(2006.01)
(86) International application number:
PCT/CA2011/050720
(87) International publication number:
WO 2013/071396 (23.05.2013 Gazette 2013/21)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(71) Applicant: Université de Montréal
Montreal, Québec H3T 1P1 (CA)

(72) Inventors:
  • BENDAYAN, Moise
    Saint-Laurent, Québec H4R 3K1 (CA)
  • CAMMISOTTO, Phillippe
    Lasalle, Québec H8R 2M6 (CA)

(74) Representative: Agasse, Stéphane et al
Cabinet GERMAIN & MAUREAU B.P. 6153
69466 Lyon Cedex 06
69466 Lyon Cedex 06 (FR)

   


(54) ORAL LEPTIN FORMULATIONS AND USES THEREOF